Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Atara Biotherapeutics, Inc. (ATRA)  
$0.67 0.02 (3.03%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 108,674,000
Market Cap: 72.81(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2298 - $2.97
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 9.4
Insider 3/6 Months : 10
Guru Rank Number :  707
Guru Rank Value     : 1.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 816,825 816,825 816,825
Total Buy Value $0 $194,885 $194,885 $194,885
Total People Bought 0 3 3 3
Total Buy Transactions 0 4 4 4
Total Shares Sold 56,192 121,276 273,751 412,845
Total Sell Value $40,460 $65,778 $342,884 $1,024,948
Total People Sold 5 6 7 9
Total Sell Transactions 5 11 22 41
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 731
  Page 6 of 30  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baynes Roy D.   •       •      –    2021-06-08 4 A $0.00 $0 D/D 11,000 23,000     -
   Koppikar Utpal Chief Financial Officer   •       –      –    2021-06-08 4 AS $14.06 $81,829 D/D (5,820) 164,948 14%     
   Yarema Kristin Chief Commercial Officer   •       –      –    2021-05-18 4 AS $14.55 $11,073 D/D (761) 91,528 20%     
   Newell Joe Chief Operations Officer   •       –      –    2021-05-18 4 AS $14.55 $35,691 D/D (2,453) 128,971 20%     
   Touchon Pascal President and CEO   •       •      –    2021-05-18 4 AS $14.55 $120,954 D/D (8,313) 359,308 20%     
   Dupont Jakob EVP, Head of R&D   •       –      –    2021-05-18 4 AS $14.55 $75,427 D/D (5,184) 94,945 20%     
   Koppikar Utpal Chief Financial Officer   •       –      –    2021-05-18 4 AS $14.55 $52,613 D/D (3,616) 168,966 20%     
   Murugan Amar SVP, GC & Secretary   •       –      –    2021-05-18 4 AS $14.55 $82,659 D/D (5,681) 91,744 20%     
   Newell Joe Chief Operations Officer   •       –      –    2021-05-17 4 AS $15.00 $52,500 D/D (3,500) 131,424 18%     
   Newell Joe Chief Operations Officer   •       –      –    2021-04-05 4 AS $14.74 $9,655 D/D (655) 134,924 -14%     
   Newell Joe Chief Operations Officer   •       –      –    2021-03-26 4 AS $14.58 $38,491 D/D (2,640) 135,579 -13%     
   Koppikar Utpal Chief Financial Officer   •       –      –    2021-03-26 4 AS $14.58 $25,675 D/D (1,761) 172,582 -13%     
   Newell Joe Chief Operations Officer   •       –      –    2021-03-15 4 AS $17.41 $121,870 D/D (7,000) 138,219 -26%     
   Newell Joe Chief Operations Officer   •       –      –    2021-03-15 4 OE $12.15 $42,525 D/D 3,500 145,219     -
   Touchon Pascal President and CEO   •       •      –    2021-03-02 4 AS $16.74 $81,808 D/D (4,887) 367,621 -17%     
   Koppikar Utpal Chief Financial Officer   •       –      –    2021-03-02 4 AS $16.74 $24,457 D/D (1,461) 174,343 -17%     
   Newell Joe Chief Operations Officer   •       –      –    2021-03-02 4 AS $16.74 $27,872 D/D (1,665) 141,719 -17%     
   Yarema Kristin Chief Commercial Officer   •       –      –    2021-03-01 4 A $0.00 $0 D/D 35,021 92,289     -
   Koppikar Utpal Chief Financial Officer   •       –      –    2021-03-01 4 A $0.00 $0 D/D 45,258 175,804     -
   Touchon Pascal President and CEO   •       •      –    2021-03-01 4 A $0.00 $0 D/D 117,187 372,508     -
   Dupont Jakob EVP, Head of R&D   •       –      –    2021-03-01 4 A $0.00 $0 D/D 53,879 100,129     -
   Murugan Amar SVP, GC & Secretary   •       –      –    2021-03-01 4 A $0.00 $0 D/D 41,756 97,425     -
   Newell Joe Chief Operations Officer   •       –      –    2021-03-01 4 A $0.00 $0 D/D 37,715 143,384     -
   Newell Joe Chief Operations Officer   •       –      –    2021-02-08 4 AS $20.39 $79,236 D/D (3,886) 105,669 -28%     
   Koppikar Utpal Chief Financial Officer   •       –      –    2021-02-08 4 AS $20.39 $35,866 D/D (1,759) 130,546 -28%     
  731 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 30
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us